GM below expectations
7% Group organic growth (Prosthetics +10%, B&S +1%) drove Group sales to USD 200m. The GM came in at 150-170bp below expectations, but was inline when adjusting for an additional $3m in restructuring costs. EBITDA pre-items came in at $33m, -8% vs ABGSCe and +3% vs company collected consensus.
Aktuellt
SENASTE
